opendata.bot
Company number
SC760230

GLOX THERAPEUTICS LIMITED

Active
✓ Active company on the official register. Next accounts due 30 September 2026.

Company details

Registered name
GLOX THERAPEUTICS LIMITED
Company number
SC760230
Registered office
JOHN ARBUTHNOTT BUILDING STRATHCLYDE UNIVERSITY OF PHARMACY & BIOMEDICAL, 161 CATHEDRAL STREET, GLASGOW, G4 0RE, SCOTLAND
Company type
Private Limited Company
Incorporated on
27 February 2023
Status
Active
Age
3 years
Nature of business (SIC)
72110 — Research and experimental development on biotechnology · 72190 — Other research and experimental development on natural sciences and engineering
Accounts — next due
30 Sept 2026
Accounts — last made up to
31 Dec 2024
Confirmation statement — next due
12 Mar 2027
Confirmation statement — last
26 Feb 2026

People with significant control

Beneficial owners holding over 25% of shares, voting rights or the right to appoint directors

G U Holdings Limited
ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors
Notified 27/02/2023
Professor Colin Kleanthous
ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent
Notified 12/04/2023
Professor Daniel Walker
ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent
Notified 12/04/2023

Corporate structure

Who controls this company, and who they control in turn

3 controllers Drag to move · scroll to zoom · double-click to expand
Company Person Current control Ended

Connections

Corporate owner owns 75–100% of shares · holds 75–100% of votes · can appoint and remove directors Control ended 12/04/2023 Controls 29 companies
Professor Colin Kleanthous
born 09/1958 · England owns 25–50% of shares · holds 25–50% of votes Control ended 13/04/2023
Professor Daniel Walker
born 02/1973 · United Kingdom owns 25–50% of shares · holds 25–50% of votes Control ended 24/10/2023

Change history

Reconstructed from the dated records Companies House publishes

DateChangeWasNow
24/10/2023 Person with significant control ceased Professor Daniel Walker
13/04/2023 Person with significant control ceased Professor Colin Kleanthous
12/04/2023 Person with significant control ceased G U Holdings Limited
12/04/2023 Person with significant control added Professor Daniel Walker
12/04/2023 Person with significant control added Professor Colin Kleanthous
27/02/2023 Person with significant control added G U Holdings Limited

Documents for GLOX THERAPEUTICS LIMITED

Need this one company on file? Buy the document on its own — no plan required.

Company extract£1.99

The full registration record as held today — name, number, status, registered office, company type, previous names, officers, PSC and SIC codes, timestamped for your file.

PDF Order
Financial statements£3.99

Every figure the company’s own accounts state, across each filed period, with year-on-year movement. Most UK companies file small or micro-entity accounts — a balance sheet and a headcount, no turnover or profit.

PDF + CSV Order
Ownership report£3.99

Who controls the company: persons with significant control, the nature of that control, the ownership graph and every other company those controllers hold.

PDF Order

Data protection register

Registered with the Information Commissioner's Office as a data protection fee payer.

Glox Therapeutics Limited — G4 0RE
Tier 1 · renews 11/07/2027
ICO entry

The ICO publishes no company number, so this is matched on the registered name and confirmed by the postcode. Check the ICO entry before relying on it.

Get this company via API

Every field on this page is available as structured JSON behind one endpoint and one API key.

GET /v1/company/gb/SC760230
X-Api-Key: $OPENDATA_KEY
Read the API docs

Frequently asked questions

What is the company number of GLOX THERAPEUTICS LIMITED?
According to the official registry, the company number of GLOX THERAPEUTICS LIMITED is SC760230.
Where is GLOX THERAPEUTICS LIMITED registered?
The registered office is JOHN ARBUTHNOTT BUILDING STRATHCLYDE UNIVERSITY OF PHARMACY & BIOMEDICAL, 161 CATHEDRAL STREET, GLASGOW, G4 0RE, SCOTLAND.
What is the SIC code of GLOX THERAPEUTICS LIMITED?
The nature of business is recorded under SIC code 72110 — Research and experimental development on biotechnology, 72190 — Other research and experimental development on natural sciences and engineering.
Who controls GLOX THERAPEUTICS LIMITED?
G U Holdings Limited is recorded as a person with significant control, with ownership of shares 75 to 100 percent, voting rights 75 to 100 percent, right to appoint and remove directors.
When are the next accounts of GLOX THERAPEUTICS LIMITED due?
The next annual accounts are due by 30 September 2026, and the last accounts were made up to 31 December 2024.

About GLOX THERAPEUTICS LIMITED (SC760230)

GLOX THERAPEUTICS LIMITED is a private limited company incorporated on 27 February 2023 and registered in the United Kingdom under company number SC760230. Its registered office is at JOHN ARBUTHNOTT BUILDING STRATHCLYDE UNIVERSITY OF PHARMACY & BIOMEDICAL, 161 CATHEDRAL STREET, GLASGOW, G4 0RE, SCOTLAND. The recorded nature of business is research and experimental development on biotechnology (SIC 72110). The company is currently active , with statutory accounts last made up to 31 December 2024. , and the person with significant control is G U Holdings Limited. This profile is provided by opendata.bot by Noetikos, aggregating official data from Companies House bulk data , last refreshed 2 September 2026.

Research and experimental development on biotechnology across UK registers

The same sector and the same company, seen through every register we hold

Explore by sector

Every UK company records what it does as a SIC code — browse the sectors around this one.